Kangmei Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600518.SS

Kangmei Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2023: USD 14.98 M

Kangmei Pharmaceutical Co., Ltd. Goodwill is USD 14.98 M for the year ending December 31, 2023, a -2.80% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Kangmei Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 15.41 M, a -7.92% change year over year.
Kangmei Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 16.74 M, a 196.00% change year over year.
Kangmei Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 5.65 M, a -51.50% change year over year.
Kangmei Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 11.66 M, a -69.27% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Shanghai Stock Exchange: 600518.SS

Kangmei Pharmaceutical Co., Ltd.

CEO	Mr. Guowei Liu
IPO Date	March 19, 2001
Location	China
Headquarters	East side of Jieshen Road
Employees	4,409
Sector	Healthcare
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.

Key trends

Past 5 years